登录

Ping An Health Cloud Announces the Agreement to Buy 20% Stake of Hydee at ¥131M

作者: Mailman 2019-11-08 15:59
海典软件
http://www.hydee.cn
企业数据由 动脉橙 提供支持
医药流通行业信息化解决方案供应商 | 新三板定增 | 运营中
中国-上海
2019-11-06
融资金额:RMB¥1.31亿
平安好医生
查看

According to Lieyunwang.com, Ping An Health Cloud Co.Ltd ("Ping An Health Cloud") announced that it has signed a definitive agreement with Hydee Software Co., Ltd. ("Hydee") whereby Ping An Health Cloud will buy a 20 percent stake of Hydee at 131 million yuan, including 49.1 million yuan for old shares before Hydee’s expansion, and 81.9 million yuan for new shares. 


Founded in December 2004, Hydee is a company focusing on developing ERP software for pharmaceutical circulation. The company provides services for pharmacies, pharmaceutical wholesalers and other enterprises in the field of pharmaceutical circulation. Relying on strong ability of R&D and concerns about customers, Hydee has developed seven categories of products and innovative services covering ERP, consulting, smart drugstore, supply chain, medical and insurance, and data traceability and so on.


Headquartered in Shanghai, Hydee has set up 6 subsidiaries in Changsha, Shenyang, Xiamen, Chongqing, Xi 'An and Jinan. Up to now, the company has provided professional services to more than 3,000 pharmaceutical enterprises and about 90,000 drugstores.


Ping An Health Cloud operates a one-stop health care solution platform in China. Its platform offers doctor appointments, medical e-commerce, follow-up visit, rehabilitation guidance, and chronic disease management solutions. The one-stop health care solution platform, which called "Ping An Good Doctor", has attracted 265 million registered users (including 54.7 million active users) at the end of the month, achieving the largest mobile medical application coverage in China. Through its own medical team and external doctors assisted by AI, "Ping An Good Doctor" provides users with one-stop services covering 7×24 hours online consultation, referral, registration, hospitalization arrangement, second diagnosis and treatment opinions, and one-hour medicine delivery.

相关赛道 医疗信息化
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

【首发】存健康获启赋资本数千万B+轮融资,加速药品流通终端数字化新基建

【首发】力美康完成2000万元pre-A轮融资,为连锁药店提供“人货场”全面赋能

Yuanxin Technology Raises ¥3 Billion in Series E Funding Round

医药指数第一季度上涨7.5%,沪指下跌8.8%——国内医疗企业二级市场第一季度表现分析

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Happiness Biotech Announces $11 Million IPO in Nasdaq

2019-11-08
下一篇

Yunnan Baiyao Invests $50M in Biopharma Firm Sinomab Bioscience as Cornerstone Investor

2019-11-08